Related Experiment Videos
Understanding NSAIDs: from aspirin to COX-2
1Department of Family Practice, UCLA School of Medicine, Los Angeles, California, USA.
Clinical Cornerstone
|July 24, 2001
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) present treatment paradoxes, with increasing use due to OTC availability and an aging population. Newer formulations like COX-2 inhibitors offer potential safety benefits, though research continues into diverse applications.
Area of Science:
- Pharmacology
- Internal Medicine
- Drug Development
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, with millions of prescriptions and over-the-counter sales annually in the US.
- Despite their long history, NSAIDs exhibit paradoxes, ranging from infant-safe OTC options to potent prescription drugs causing severe adverse events.
Purpose of the Study:
- To provide practitioners with a comprehensive overview of NSAID types, including novel cyclooxygenase-2 (COX-2) selective inhibitors.
- To discuss the mechanism of action, efficacy, and potential adverse reactions associated with various NSAIDs.
- To explore emerging nontraditional applications and a new framework for NSAID development.
Main Methods:
- Review of existing literature on NSAID pharmacology and clinical use.
- Analysis of trends in NSAID prescription and over-the-counter sales.
- Examination of the development and market introduction of new NSAID formulations, including COX-2 inhibitors.
Main Results:
- NSAID use is increasing, driven by OTC availability and an aging population with conditions like osteoarthritis.
- Newer COX-2 selective inhibitors rapidly gained popularity upon their introduction.
- A spectrum of NSAID safety and efficacy exists, posing choices for prescribers.
Conclusions:
- Understanding the diverse profiles of NSAIDs, including newer COX-2 agents, is crucial for effective and safe patient management.
- Ongoing research is expanding the therapeutic landscape for NSAIDs beyond traditional indications.
- A evolving framework supports the development of future NSAID medications.